|
1
|
Expression of prohibitin 3' untranslated region suppressor RNA alters morphology and inhibits motility of breast cancer cells.
|
J Mol Histol
|
2004
|
0.89
|
|
2
|
Influence of KGF on the progression of pancreatic cancer.
|
Anticancer Res
|
2009
|
0.84
|
|
3
|
Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration.
|
Anticancer Res
|
2006
|
0.83
|
|
4
|
KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2.
|
Clin Exp Metastasis
|
2004
|
0.82
|
|
5
|
Influence of novel KGFR tyrosine kinase inhibitors on KGF-mediated proliferation of breast cancer.
|
Anticancer Res
|
2010
|
0.81
|
|
6
|
Keratinocyte growth factor stimulates the migration and proliferation of breast cancer cells in a culture wounding model.
|
Pharmacol Res
|
2002
|
0.80
|
|
7
|
Antisense KGFR oligonucleotide inhibition of KGF-induced motility in breast cancer cells.
|
Anticancer Res
|
2004
|
0.80
|
|
8
|
SiRNA inhibition of ER-alpha expression reduces KGF-induced proliferation of breast cancer cells.
|
Anticancer Res
|
2008
|
0.79
|
|
9
|
Specific and non-specific KGF inhibition of KGF-induced breast cancer cell motility.
|
Anticancer Res
|
2003
|
0.78
|
|
10
|
The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells.
|
Anticancer Res
|
2002
|
0.78
|
|
11
|
Enhanced motility of KGF-transfected breast cancer cells.
|
Anticancer Res
|
2006
|
0.78
|
|
12
|
Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation.
|
Cancer Chemother Pharmacol
|
2003
|
0.77
|
|
13
|
Development of keratinocyte growth factor receptor tyrosine kinase inhibitors for the treatment of cancer.
|
Anticancer Res
|
2008
|
0.76
|
|
14
|
Wilms' tumor 1 protein and focal adhesion kinase mediate keratinocyte growth factor signaling in breast cancer cells.
|
Anticancer Res
|
2008
|
0.75
|
|
15
|
Selective growth inhibition of cancer cells by L-methioninase-containing fusion protein targeted to the urokinase receptor.
|
Pharmacology
|
2009
|
0.75
|
|
16
|
Influence of L-methioninase targeted to the urokinase receptor on the proliferation and motility of lung and prostate cancer cells.
|
Anticancer Res
|
2007
|
0.75
|
|
17
|
Effect of antiestrogens on EGF-mediated movement of human breast cancer cells.
|
Pharmacology
|
2006
|
0.75
|